United States · FDA National Drug Code directory
Glipizide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68788-8512_a449105d-4a45-49c7-91b8-ea3ddc223723
- Product NDC
- 68788-8512
- Form
- TABLET
- Composition / generic term
- Glipizide
- Labeler
- Preferred Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230825
- Source listing expiry
- 20271231
Source-listed ingredients
- GLIPIZIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE, PLASTIC (68788-8512-1) · 68788-8512-1
- 30 TABLET in 1 BOTTLE, PLASTIC (68788-8512-3) · 68788-8512-3
- 60 TABLET in 1 BOTTLE, PLASTIC (68788-8512-6) · 68788-8512-6
- 180 TABLET in 1 BOTTLE, PLASTIC (68788-8512-8) · 68788-8512-8
- 90 TABLET in 1 BOTTLE, PLASTIC (68788-8512-9) · 68788-8512-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →